Results 71 to 80 of about 26,051 (185)

Right Ventricular Dysfunction and Ventriculo‐Arterial Uncoupling in Heart Failure With Preserved Ejection Fraction: A Phenotype‐Specific Review of Mechanisms, Diagnosis, and Therapeutic Strategies

Clinical Cardiology, Volume 49, Issue 11, November 2026.
Right ventricular dysfunction affects 19%–33% of patients With heart failure With preserved ejection fraction and is associated With exercise intolerance, hospitalization, and mortality. Assessing right ventricular function and its coupling with the pulmonary circulation may improve risk stratification and support management tailored to distinct ...
Amarelle Chamoun, Talha Farooq, Suhayya Batool, Sadia Tameez‐ud—din, Muhammad Yousaf, Preet Memon, Mohsin Ali, Arun Kumar Maloth, F. N. U. Sawaira, Muhammad Taimur Khan, Mohammad Eisa Ali, Mansoor Khalid, Maleeha Pandit, Kamil Ahmad Kamil   +13 more
wiley   +1 more source

Cardiac amyloidosis [PDF]

Canadian Journal of Cardiology, 2008
Ali K, Salah, Agha, Ahmed, Kunal N, Bodiwala, Elizabeth J, Manaloor, John W, Thornton, David J, Moliterno   +5 more
openaire   +2 more sources

Atrial cardiomyopathy

ESC Heart Failure, Volume 12, Issue 2, Page 727-729, April 2025.
Wojciech Kosmala, Monika Przewłocka‐Kosmala   +1 more
wiley   +1 more source

Old disease, new twist

Journal of Hospital Medicine, Volume 21, Issue 11, Page 1305-1309, November 2026.
Abstract An 81‐year‐old man with a history of high‐grade urothelial carcinoma of the bladder and ureter on treatment with atezolizumab and tiragolumab presented to the emergency department with 5 months of malaise, generalized weakness, and fatigue and 2 weeks of subjective fevers. One month prior to presentation, he received an empiric 9‐day course of
Hadi Roudsari, Gurpreet Dhaliwal, Anand D. Jagannath, Alan H. Baik, Sam Brondfield   +4 more
wiley   +1 more source

Nucleic Acid Therapeutics in Rare Disease: From Precision Medicine to Programmable Platforms

Journal of Inherited Metabolic Disease, Volume 49, Issue 6, November 2026.
ABSTRACT Nucleic acid therapeutics (NATs), including antisense oligonucleotides (ASOs), small interfering RNAs (siRNAs), messenger RNA (mRNA) therapeutics and programmable editing technologies, are reshaping the therapeutic landscape for inherited metabolic and genetic disease.
Tomasz Z. Tomkiewicz, Siyamini Sivananthan, Paul Gissen, Haiyan Zhou   +3 more
wiley   +1 more source

Neurodegenerative Diseases: Epidemiology, Risk Factors, Classification, Pathophysiology, Clinical Features, Diagnosis, and Therapeutic Strategies

MedComm, Volume 7, Issue 11, November 2026.
Neurodegenerative diseases share convergent risk architectures and pathological mechanisms, yet diverge in selective vulnerability, clinical presentation, and therapeutic responsiveness. This review integrates cross‐disease epidemiology, pathophysiology, diagnosis, and treatment, highlighting the transition from symptomatic care toward biomarker‐guided
Zimeng He, Jingjing Zeng, Guoqing Wang, Yuxin Li, Feng Zhang   +4 more
wiley   +1 more source

Cardiac Amyloidosis Versus Other Restrictive Cardiomyopathies: A Retrospective Analysis of Cardiovascular Outcomes and Arrhythmic Burden

Clinical Medicine Insights: Cardiology
Background: The arrhythmic burden and cardiovascular risks of cardiac amyloidosis compared with other types of restrictive cardiomyopathies (RCM), such as hemochromatosis and cardiac sarcoid, have not been well characterized in the literature.
Andrew Sagalov, Waqas Ullah, Yevgeniy Brailovsky, Michael Buhnerkempe, Steve Scaife, Abhishek Kulkarni, Mohamed Labedi, Shruti Hegde   +7 more
doaj   +1 more source

Senile cardiac amyloidosis: types, structural and functional characteristics, clinical forms, morphological diagnosis (literature review)

Известия высших учебных заведений. Поволжский регион: Медицинские науки
Amyloidosis is a disease caused by the deposition of proteins with an unstable tertiary structure, which coagulate and accumulate in tissues as glycoprotein fibrils.
Nikita S. Averkin, Yana S. Budnikova, Zhanna S. Vishnyakova, Valeria A. Larionova, Oksana P. Evseeva   +4 more
doaj   +1 more source

Genetic Insights Into Cardiomyopathy With Restrictive Phenotype: Implications for Diagnosis and Personalized Care

Molecular Genetics &Genomic Medicine, Volume 14, Issue 11, November 2026.
Among 568 patients with cardiomyopathy, 33 exhibited a restrictive phenotype, including 7 with RCM, 20 with HRCM, and 6 with HDRCM. Pathogenic or likely pathogenic variants were identified in 24 patients (72.7%). Variant carriers had a smaller aortic sinus diameter than non‐carriers (30.79 ± 3.48 vs.
Nianwei Zhou, Yi Sun, Xuemei Wei, Wenwen Liang, Fangmin Meng, Zhengdan Ge, Minmin Sun, Xiaotong Cui, Shuning Zhang, Cuizhen Pan, Junbo Ge, Xianhong Shu   +11 more
wiley   +1 more source

A thousand words about the imaging in cardiac amyloidosis

Journal of Medical Science, 2019
Cardiac amyloidosis is an infiltrative disease which usually occurs under the form of restrictive cardiomyopathy. Advances in the treatment have changed the unfavorable outcomes of this disease. Thus, early diagnosis is essential.
Rafał Dankowski, Marek Leszniewski, Małgorzata Pyda, Andrzej Szyszka   +3 more
doaj   +1 more source